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Abstract
Objective: Ecstasy, also known as 3, 4-methylenedioxymethamphetamine (MDMA), is a 
psychoactive recreational hallucinogenic substance and a major worldwide recreational 
drug. There are neurotoxic effects observed in laboratory animals and humans following 
MDMA use. MDMA causes apoptosis in neurons of the central nervous system (CNS). 
Withdrawal signs are attenuated by treatment with the adenosine receptor (A2A receptor). 
This study reports the effects of  glutamyl cysteine synthetase (GCS), as an A2A receptor 
agonist, and succinylcholine (SCH), as an A2A receptor antagonist, on Sprague Dawley 
rats, both in the presence and absence of MDMA.
Materials and Methods:  In this experimental study, we used seven groups of Sprague 
Dawley rats (200-250 g each). Each group was treated with daily intraperitoneal (IP) injec-
tions for a period of one week, as follows: i. MDMA (10 mg/kg); ii. GCS (0.3 mg/kg); iii. 
SCH (0.3 mg/kg); iv. GCS + SCH (0.3 mg/kg each); v. MDMA (10 mg/kg) + GCS (0.3 mg/
kg); vi. MDMA (10 mg/kg) + SCH (0.3 mg/kg); and vi. normal saline (1 cc/kg) as the sham 
group. Bax (apoptotic protein) and Bcl-2 (anti-apoptotic protein) expressions were evalu-
ated by striatum using RT-PCR and Western blot analysis. 
Results: There was a significant increase in Bax protein expression in the MDMA+SCH 
group and a significant decrease in Bcl-2 protein expression in the MDMA+SCH group 
(p<0.05).  
Conclusion: A2A receptors have a role in the apoptotic effects of MDMA via the Bax and 
Bcl-2 pathways. An agonist of this receptor (GCS) decreases the cytotoxcity of MDMA, 
while the antagonist of this receptor (SCH) increases its cytotoxcity. 
Keywords: Ecstasy or MDMA, Neurotoxicity, Adenosine Receptor, Agonist of A2A Recep-
tor, Antagonist of A2A Receptor  
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Introduction
Ecstasy (3, 4-methylenedioxymethamphetamine; 
MDMA) is a psychoactive, recreational, halluci-
nogenic drug abused worldwide. Several studies 
express concern that MDMA has the ability to in-
duce neurotoxic effects both in laboratory animals 
and humans. Despite more than two decades of 
research, the neurotoxic mechanisms of MDMA 
are not clear. MDMA induces serotonergic termi-
nal loss in rats and some mice strains, and broader 
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neuronal degeneration throughout several brain 
areas such as the cortex, hippocampus, and 
striatum. In human ecstasy abusers, there is 
evidence for deficits in seronergic biochemical 
markers (1, 2).
MDMA causes hallucination and psycho-
stimulation, as well as long-term neuropsychi-
atric behaviors such as panic and psychosis. In 
rodents and monkeys, MDMA is cytotoxic to 
serotonergic neurons, but this is less clear with 
humans (3). The onset of its effect can take 20 
to 60 minutes to occur, with a peak at 60 to 90 
minutes following ingestion. The primary ef-
fects last for 3 to 5 hours. MDMA usually in-
duces a relaxed, euphoric state, including emo-
tional openness, empathy, reduction of negative 
thoughts, and a decrease in inhibitions. Sounds 
and colors can appear more intense. Accompa-
nying physiological changes can result in se-
vere adverse events (4). The evidence that im-
paired serotonergic function may be associated 
with memory deficits in MDMA users is further 
shown by correlations between alterations in 
cortical 5-HT2A receptor binding, altered D-
fenfluramine-induced cortisol responses, and 
memory deficits. Reneman et al. have demon-
strated higher overall 5-HT2A receptor binding 
ratios in the brains of an MDMA user group. 
MDMA-induced 5-HT depletion results in the 
up-regulation of 5-HT2 receptors. MDMA us-
ers show significant deficits in delayed mem-
ory tasks, which directly correlates with the 
increase in 5-HT2A receptor binding ratios. 
Verkes et al. have observed a significantly re-
duced cortisol response to D-fenfluramine in 
MDMA users compared to control subjects. 
Those who used MDMA also had significant-
ly longer reaction times to visual and auditory 
stimuli, lower visual recall, and lower working 
memory scores. The reduced cortisol response 
correlates significantly with visual recall 
scores, indicating a significant association be-
tween chronic MDMA use, diminished memory 
performance, and serotonergic neuroendocrine 
functional deficits (4). 
The mechanism of MDMA-induced depletion 
of the central nervous system (CNS) serotonin 
(5-hydroxytryptamine, 5-HT) is believed to in-
volve the generation of reactive oxygen species 
(5). The process of apoptosis is controlled by a 
diverse range of cell signals, which may origi-
nate either extracellularly via extrinsic inducers 
or intracellularly via intrinsic inducers. Extra-
cellular signals may include toxins, hormones, 
growth factors, oxides or cytokines, which must 
either cross the cell membrane or transduce to 
affect a response. These signals may positively 
(trigger) or negatively (inhibit) affect apopto-
sis. A cell initiates intracellular apoptotic sign-
aling in response to a stress or cell suicide. The 
binding of nuclear receptors by glucocorticoids, 
heat, radiation, nutrient deprivation, viral infec-
tion, hypoxia and increased intracellular cal-
cium concentration (by damage to the mem-
brane) can all trigger the release of intracellular 
apoptotic signals by a damaged cell. A number 
of cellular components regulate apoptosis. The 
Bcl-2 protein is able to inhibit apoptosis by di-
rect action, while Bax and/or Bak promote apo-
ptosis (6). Various stressors and hypothermia 
protect against d-MDMA-induced neurotoxici-
tythrough unknown mechanisms (7-10). 
Adenosine, a nucleoside produced by cells 
and tissues in response to a variety of physical 
and metabolic stresses, mediates physiological 
activities that include sedation, inhibition of 
platelet aggregation, and vasodilatation (11). In 
addition to the dopaminergic pathways, the in-
volvement of neurotransmitter and neuromodu-
lator systems in opioid-dependent mechanisms 
is documented. The glutamatergic and ami-
nobutyric acid (GABAergic) systems are the 
most engaged in opioid dependence, although 
the role of other modulators, such as nitric ox-
ide or adenosine, cannot be ruled out. Endog-
enous adenosine, a potent inhibitory neuromod-
ulator in the CNS, is known to affect the state 
of dependence. For example, opioid, ethanol, or 
benzodiazepine withdrawal signs are attenuated 
by treatment with adenosine receptors or A2A 
agonists (12).
A2A is a member of the G protein-coupled re-
ceptor family. The A2A receptor is also expressed 
in the brain, where it plays a role in regulation of 
glutamate and dopamine release, thus making it 
a potential therapeutic target for the treatment of 
conditions such as pain, depression, drug addic-
tion, and Parkinson’s disease. The A2A receptor 
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has some agonists such as  glutamyl cysteine syn-
thetase (GCS), in addition to antagonists such as 
caffeine and (SCH) (13).
2-p-(2-carboxyethyl) phenethylamino-5’-N-ethyl-
carboxamidoadenosine hydrochloride (CGS 21680) 
and 5’-N-ethylcarboxamidoadenosine (NECA) in-
hibit the initiation of cocaine self-administration. 
According to research, CGS 21680 and NECA in-
hibit the development of sensitivity to diazepam 
withdrawal signs, whereas adenosine receptor an-
tagonists intensify diazepam and temazepam with-
drawal signs. 
The adenosinergic system is well-recognized 
as an important modulator of dependence, but 
less is known about the effects of adenosine li-
gands on the development of hypersensitivity to 
acute morphine doses that are injected during 
morphine withdrawal periods. MDMA causes 
apoptosis in brain tissue and A2A receptors can 
mediate apoptosis in cells via both known and 
unknown pathways. The present study is un-
dertaken to investigate the role of the selective 
adenosine A2A receptor on apoptosis caused by 
MDMA (11, 12, 14).
Materials and Methods
Animals
The experiments were performed on male 
Sprague Dawley rats (weights: 200–250 g each). 
Animals were kept three to four per cage at a room 
temperature of 22 ± 1˚C on natural day-night cy-
cles (Spring). Standard nutrition and tap water 
were freely available. All the experiments were 
performed between 9 am and 2 pm.
Groups
We divided the rats into seven groups. Each 
group was treated with daily intraperitoneal (IP) 
injections for a period of one week, as follows: i. 
MDMA (10 mg/kg); ii. GCS (0.3 mg/kg); iii. SCH 
(0.3 mg/kg); iv. GCS + SCH (0.3 mg/kg each); 
v. MDMA (10 mg/kg) + GCS (0.3 mg/kg); vi. 
MDMA (10 mg/kg) + SCH (0.3 mg/kg); and vii. 
normal saline (1 cc/kg) as the sham group. 
Surgery
After two weeks injections the animals were eu-
thanized and their striata removed immediately for 
total RNA and protein extraction, and maintained 
in N2 in  frized at -70˚C.
Western blot analysis
Proteins were extracted by using the RiPA buff-
er (Gibco, USA) and a cocktail protein inhibitor 
(Gibco, USA). The concentration of protein was 
analyzed with Bio-rad protein assay buffer. Pro-
tein was run in a 12% polyacrylamid gel and then 
transferred onto a nitrocellulose membrane after 
which immunoblotting was performed. We used a 
primary antibody against Bcl-2 and Bax (Sigma, 
USA) followed by rat monoclonal secondry an-
tibody for IgG FITC. After the addition of BCIP 
solution the bands were visualized, scanned, and 
analyzed with UVItec software version 12.6 (13).
Reverse transcription PCR 
The total RNA from striatum was isolated 
with TRIzol® (Gibco/Invitrogen, USA) fol-
lowing the manufacturer’s protocol. The PCR 
reaction mixture  50 µl consisted of 2 µl cDNA 
in PCR buffer [20 mM tris-HCl (pH= 8.4) and 
50 mM KCl] that contained 0.2 mM dNTP 
mix, 4.5 mM MgCl2, 100 ng each of forward 
and reverse primers, and 1 U Platinum TaqD-
NA polymerase (Gibco/Invitrogen,  USA). ss-
cDNA (cDNA) was synthesized and amplified 
using specific primers chosen from NCBI for 
rotin genes.The following primers were used: 
Bcl-2 
Forward: 5'-GGT GCC ACC TGT GGT CCA CCT G-3' 
Reverse:  5'-CTT CAC TTG TGG CCC AGA TAG G-3' 
Bax 
Forward: 5′-GGT TTC ATC CAG GAT CGA GAC GG-3′ 
Reverse: 5′-ACA AAG ATG GTC ACG GTC TGC C-3′
GAPDH 
Forward: 5'-CTG TGT GGA CTT GGG AGA GG-3' 
Reverse: 5'-GGC ATC CAC GAA ACT ACC TT-3'
The PCR product was separated by electro-
phoresis on 2% agarose gels that contained 
ethidium bromide (0.15 mg/ml), subsequently 
visualized with a UV transilluminator  UV-tec, 
Germany, and digitally photographed. The am-
plicon was quantified densitometrically using 
Kodak Digital Science software (13).
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Statistical analysis
We repeated all experiments a minimum of 
three times, from which qualitatively identi-
cal results were obtained. Differences between 
groups were analyzed using the student’s t test 
or appropriate level of ANOVA. Statistical 
analyses were performed with the Statistical 
Package for the Social Sciences (SPSS, ver-
sion 18). A p<0.05 was considered statistically 
significant.
Ethical considerations
The study was approved by the Ethics Com-
mittee of Tehran University of Medical Sciences 
(TUMS).
Results
Western blot analysis showed decreased ex-
pression of the Bcl-2 protein in the MDMA+ 
SCH group compared to the other groups 
(p<0.05). Bax protein expression in the MDMA 
+ SCH group increased in contrast to the other 
groups (Figs 1-4). Results of RT-PCR showed a 
meaningful increase of Bax mRNA expression 
in the MDMA + SCH group in contrast to the 
other groups, and decreased Bcl-2 mRNA ex-
pression in this same group in contrast to the 
MDMA group (p<0.05; Fig 5).
Fig 1: Increase of  Bax protein in the MDMA + SCH group.
Lane number 1: GCS, 2:MDMA + GCS, 3: Control, 4: 
MDMA, 5: MDMA + SCH, 6:SCH
Fig 2: Decreased Bcl-2 protein expression in the 
MDMA+SCH group. Lane number 1: SCH, 2: MDMA + 
SCH, 3: Control, 4: MDMA, 5: MDMA + GCS, 6: GCS.
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Fig 3: Increased Bax protein in the MDMA + SCH group.
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Fig 4: Bcl-2 protein expression in the MDMA+SCH group.
Fig 5: Decreased Bcl-2 mRNA expression in MDMA+SCH 
group compared to MDMA group.
Discussion
Exposure to 15 mg/kg of methamphetamine can 
produce cell death in the mouse   hippocampus af-
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ter five days (15). A different study shows that ex-
posure of this drug at a dose of 4 mg/kg, four times 
per day results in cell death (16). 
Research shows that cell death is the same as 
apoptosis (17-19). In this study we have noted that 
apoptosis plays a considerable role in cell dam-
age caused by MDMA. Some studies show that 
MDMA can result in cell-to-cell interaction or 
cell-to-matrix interaction and chronic changes in 
neurons (20). The deregulations of methampheta-
mine relate to the production of super oxide and 
free radicals (21). In animal models, MDMA in-
creases locomotoric actions (22), which occur be-
cause of serotonin release (23).
Jayanthi and coworkers have shown that MDMA 
exposure changed the expression of Bcl-2 in rat 
brains, increased the expression of Bad, Bax, and 
Bid, and decreased the expression of Bcl-2 and 
Bcl-xl (24).
Previous studies have shown that A2A adenosine 
receptors mediate the neural pathway excited by 
drugs. In addition to activation, these receptors can 
result in the release of certain neurotransmitters in 
the brain such as dopamine and glutamine, which 
affect behavioral development (25). A2A receptors 
have an important role in long–term responses to 
dopaminergic excitatory drugs in rats and mon-
keys (26). The CGS 21680 A2A agonist receptor 
reduces sensitization to methamphetamines (27) 
and GCS decreases the stereotypy of methamphet-
amines (28).
The supportive role of A2A receptors in the re-
duction of neural defects due to ischemia is shown 
by a decrease in apoptosis after the use of A2A 
receptor agonists that are related to the changes 
of expression in Bax and Bcl-2 genes (25). We 
have focused on the role of apoptosis in MDMA 
cell damage and the corporation of A2A recep-
tor in that. Our results have shown that the use 
of A2A receptor agonists decreased the effect of 
MDMA. Thus, the A2A receptor has an important 
role in the effect of  MDMA on  brain damage. 
As a result of the analysis of Bax and Bcl-2 pro-
teins, this role  has been determined to be related 
to apoptosis. We showed this mechanism occurred 
via a change in Bax and Bcl-2 expression. We also 
demonstrated that exposure to 10 mg/kg MDMA 
after one week increased Bax protein expression 
and caused a decrease in Bcl-2 protein expression. 
Our results showed that the use of GCS can reduce 
side effects of MDMA by causing increased Bcl-2 
expression and decreased Bax expression. Our re-
sults agreed with those of other studies. Additional 
studies should be performed to test the other ef-
fects of GCS in the brain and  confirm  the use of it 
to decrease MDMA effects.
Conclusion
The use of A2A receptor agonists in this drug 
can reduce some of the side effects of MDMA.
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